April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
March 15, 2023 View Now | CP-RND: An Introduction to the Patient Community Hosted by the C-Path team, you can view this recorded webinar to learn more about the Critical Path for Rare Neurodegenerative Dis
November 15, 2022-November 17, 2022 Selecting Outcomes That Are Truly Meaningful to Patients Panel discussion at the National Organization of Rare Disorders (NORD) Breakthrough Summit in Washington, DC, held October 15 –
April 13, 2022-April 14, 2022 13th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 13–14, 2022 On April 13–14, 2022, the 13th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual for
June 27, 2021-July 1, 2021 The Rare Disease Clinical Outcome Assessment Consortium: Collaboration Aimed at Accelerating Rare Disease Drug Development Presented at the DIA Virtual Global Annual Meeting, held June 27 – July 1, 2021.
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
June 12, 2020-June 18, 2020 The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.
The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Appropriate endpoint selection for rare disease trials is challenging. The Rare Disease Clinical Outcome Assessment (COA)....
